Organised by Prof. Dr. Jerzy Adamski (Research Unit Molecular Endocrinology and Metabolism,
Helmholtz Zentrum Munich, Neuherberg, Germany)
Co-organised by Biocrates Life Sciences AG


Date & Time:
November 13, 2018, 09:00-18:00

Klinikum der LMU München, Campus Großhadern, Hörsaal 6, Marchioninistraße 15, 81377 Munich, Germany


Participation is free of charge but room capacity is limited. Please register at: 

This scientific symposium will address topics such as
• Gut-liver-heart and gut-liver-brain axis: how our intestinal microbiota determines the course of diseases
• Nutrition, bugs and drugs: how modulating metabolism affects outcomes
• Systems biology: how metabolomics contributes to a holistic understanding of pathophysiology

Who should attend?
Biomedical researchers interested in metabolism, metabolomics, metagenomics and/or systems biology.


Detailed Program

09:00 - 9:30
Dr. Till Strowig & Prof. Dr. Karsten Hiller, Research Area Immunometabolism, Helmholtz Centre for Infection Research, Braunschweig, Germany
Functional Microbiomics in Disease

09:30 - 10:00
Prof. Dr. Sabine Kulling, Department of Safety and Quality of Fruit and Vegetables, Max Rubner Institute, Karlsruhe, Germany
Gut Microbiota Signatures of Resveratrol Metabolism in Humans

10:00 - 10:30
Prof. Dr. Korinna Huber, Functional Anatomy of Livestock, University of Hohenheim, Hohenheim, Germany
Metabolomics in Farm Animals - a Targeted Approach to Identify Metabolic Inflammation

10:30 - 11:00 Coffee break

11:00 - 11:30
Prof. Rima Kaddurah-Daouk, Duke Institute for Brain Sciences, Duke University, Durham, NC, USA
Gut-Microbiome-Liver-Brain Axis in Alzheimer’s Disease

11:30 - 12:00
Dr. Corinne Benakis, Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians-University Munich, Munich, Germany
Microbiota Affects Immune and Metabolic Responses After Stroke

12:00 - 12:30
Prof. Dr. Norbert Stefan, Institute for Diabetes Research and Metabolic Diseases, University of Tuebingen, Tuebingen, Germany
Gut-Liver Axis: The Importance of the Microbiome in ­Metabolic Diseases
12:30 - 13:30 Lunch break

13:30 - 14:00
Dr. Therese Koal, Head of R&D, Biocrates Life Sciences AG, Innsbruck, Austria
Microbiome Meets Metabolome

14:00 - 14:30
Dr. Sabine Kahl, Institute for Clinical Diabetology, German Diabetes Center, Duesseldorf, Germany
Fructose & Liver Function in Metabolic Disease

14:30 - 15:00
Prof. Dr. Susanne Klaus, Department of Physiology of Energy Metabolism, German Institute of Human Nutrition, Potsdam, Germany
Short-Chain Fatty Acids Prevent Diet Induced Obesity and Insulin Resistance

15:00 - 15:30 Coffee break

15:30 - 16:00
Stefan Pietzsch, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
Insulin Supplementation Attenuates Cancer-Induced Cardiomyopathy and Slows Tumor Disease Progression

16:00 - 17:00
Roundtable: Metabolomics as an Essential Research Tool in Systems Biology
Dr. Wulf Fischer-Knuppertz, CEO, Biocrates Group, Innsbruck Austria
Prof. Dr. Jerzy Adamski, Helmholtz Zentrum München, Munich, Germany

17:00 - 18:00 Get together
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok Decline